Maxcyte (MXCT) Long-Term Investments (2023 - 2026)
Maxcyte (MXCT) posted quarterly Long-Term Investments of $40.8 million for Q1 2026, up 12.05% year-over-year from $36.4 million in Q1 2025, and down 22.37% quarter-over-quarter from $52.6 million in Q4 2025.
Maxcyte (MXCT) Long-Term Investments (2023 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Long-Term Investments for 4 consecutive years, with $40.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Investments rose 12.05% year-over-year to $40.8 million; the TTM figure through Mar 2026 stood at $40.8 million (up 12.05% YoY), while the FY2025 annual figure was $52.6 million, up 46.92% from the prior year.
- Long-Term Investments fell to $40.8 million in Q1 2026 per MXCT's latest filing, from $52.6 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $52.6 million in Q4 2025 and bottomed at $18.4 million in Q3 2023.
- Historically, Long-Term Investments has averaged $40.7 million across 4 years, with a median of $42.5 million in 2024.
- Annual changes were most pronounced in 2024 — Long-Term Investments soared 132.23% — and 2025, when it dropped 19.12%.
- Maxcyte's Long-Term Investments stood at $42.9 million in 2023, then decreased by 16.67% to $35.8 million in 2024, then jumped by 46.92% to $52.6 million in 2025, then declined by 22.37% to $40.8 million in 2026.
- Business Quant data shows MXCT's Long-Term Investments at $40.8 million in Q1 2026, $52.6 million in Q4 2025, and $52.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 146.35 Mn | 146.35 Mn | 5.60 Mn | 36.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.23 Mn |
| Mar 31, 2026 | 40.81 Mn |
| Dec 31, 2025 | 52.57 Mn |
| Sep 30, 2025 | 52.27 Mn |
| Jun 30, 2025 | 38.60 Mn |
| Mar 31, 2025 | 36.42 Mn |
| Dec 31, 2024 | 35.78 Mn |
| Sep 30, 2024 | 42.80 Mn |
| Jun 30, 2024 | 42.48 Mn |
| Mar 31, 2024 | 45.03 Mn |
| Dec 31, 2023 | 42.94 Mn |
| Sep 30, 2023 | 18.43 Mn |